Follow the SpectraCure AB (publ) share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, SpectraCure AB (publ) has published 7 public disclosures. Market capitalisation: €23.7m. The latest transaction was disclosed on 24 January 2026 (Purchase). Among the most active insiders: Masoud Khayyami. The full history is openly available.
7
Insider Decl.
n/a
Thresholds
€77,276
6 ops.
Buy Volume
€4,133
1 ops.
Sell Volume
33Σ signal
Buys €77,276€4,133 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
4,809 shares@ €0.01620.0003% mcap100.0% of flowBTU (betald tecknad unit)ISINISIN SE0025165699FI:A003Q127-1
7 of 7 declarations
About SpectraCure AB (publ)
SpectraCure AB (publ) is a Swedish company focused on developing innovative cancer treatments using light technology to target tumor cells. It is listed on the XSTO market.